This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Dongkook Pharmaceutical Co., Ltd.. Active years: 2000-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2001
Title: Mi Kyeong Lee: Innovator in Liver Protection
Introduction
Mi Kyeong Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of liver protection and treatment. With a focus on innovative solutions, he has developed methods that aim to improve liver health.
Latest Patents
Mi Kyeong Lee holds 2 patents related to liver protection. His latest patents include "Liver protection or treatment agents comprising asiatic acid derivatives as the active component." This patent discloses compositions and methods for treating or preventing hepatotoxicity utilizing asiatic acid derivatives of Formula 1. Another notable patent involves "Asiatic acid derivatives having modified A-ring," which further explores the potential of these compounds in liver treatment.
Career Highlights
Mi Kyeong Lee is associated with Dongkook Pharmaceutical Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His research and development efforts have positioned him as a key figure in the pharmaceutical industry, particularly in the area of liver health.
Collaborations
Mi Kyeong Lee has collaborated with notable colleagues, including Sang Sup Jew and Hyeung Geun Park. These partnerships have enhanced his research capabilities and contributed to the advancement of liver treatment methodologies.
Conclusion
Mi Kyeong Lee's work in liver protection showcases his dedication to improving health outcomes through innovation. His patents reflect a commitment to developing effective treatments that can benefit many individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile